A federal judge on Thursday refused to temporarily block the Trump administration’s mass layoff of federal workers while a ...

Dynavax Technologies Corporation ( NASDAQ: DVAX) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Paul Cox - Vice President, Investor Relations & Corporate Communications Ryan Spencer - ...

Achieved $61.5 million and $172.0 million in fourth quarter and full year 2024 OGSIVEO® (nirogacestat) U.S. net product revenues, respectively ...

The Senate voted to confirm Kash Patel as FBI director, a decision that places him atop the nation’s premier federal law ...

Trial decision follows unanticipated events of elevated unconjugated bilirubin levelsCompany advancing multiple next-generation PTH1R agonists ...

OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has entered into ...

for UK Clinical Trial Authorisation (CTA) to undertake a Phase 1 trial of I-ATT001, its Iodine-123 labelled PARP inhibitor in patients with recurrent glioblastoma, an aggressive form of brain cancer.

Specialists claim using blockchains in capital markets could cut costs, partly because fewer entities would need to ...

President Donald Trump created the so-called Department of Government Efficiency via executive order as a temporary ...

The drug candidate is administered orally in the form of a film-coated tablet ... predictable and reliable timescales for Clinical Trial Authorisation applications, so that sponsors can plan ...